This Guideline supersedes guideline REG-29 version 3 with the effect from January 1 2017.
- Legal sources and related regulations
- Medicinal product name – term and general definition
- General criteria for the assessment of medicinal product name in relation with its compliance with legal regulations within the scope of marketing authorisation procedure
- Special rules for the names of particular types of medicinal products
- Preliminary assessment of medicinal product name
- Reporting of medication errors related to similarity of product names
- Medicinal product name in Braille